DADC
BEAT

D.A. Davidson & Co’s BioTelemetry, Inc. BEAT Stock Holding History

D.A. Davidson & Co’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,291
Closed -$143K – 2351
2017
Q2 		$143K Sell
4,291
-1,603
-27% -$47.8K ﹤0.01% 1107
2017
Q1 		$170K Hold
5,894
– – ﹤0.01% 1012
2016
Q4 		$131K Buy
+5,894
New +$115K ﹤0.01% 1186
2016
Q3 		– Sell
-2,225
Closed -$36K – 2577
2016
Q2 		$36K Buy
+2,225
New +$32.7K ﹤0.01% 1541

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.A. Davidson & Co's BEAT Position: Q3 2017 in Review

D.A. Davidson & Co sold out of BioTelemetry, Inc. (BEAT) in Q3 2017, closing a stake of 4,291 shares — an estimated $143K sold.

D.A. Davidson & Co first reported a position in BEAT in Q2 2016 and held it in 4 quarters. The position peaked at $170K in Q1 2017. 211 funds tracked by Wall St. Rank hold BEAT as of Q3 2017.

  • D.A. Davidson & Co reported no remaining BioTelemetry, Inc. position as of Q3 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 4,291 BioTelemetry, Inc. shares in Q3 2017, an estimated $143K.
  • D.A. Davidson & Co first reported a position in BioTelemetry, Inc. in Q2 2016 and held it in 4 quarters.
  • D.A. Davidson & Co's BioTelemetry, Inc. position peaked at $170K in Q1 2017.
  • 211 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.